Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2725 studies found for:    ovarian cancer
Show Display Options
Rank Status Study
21 Recruiting DOD Long-Term Survivors of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Quality of life questionaire
22 Withdrawn CA-125 in Screening Patients at High Risk for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Other: physiologic testing;   Procedure: study of high risk factors
23 Completed Women Surviving Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Quality of Life;   Survivorship
Intervention: Behavioral: questionnaires
24 Completed Ovarian Cancer Patient Questionnaire on Genetic Testing
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
25 Terminated Sexual Functioning After Primary Treatment of Ovarian Cancer
Conditions: Ovarian Cancer;   Sexual Dysfunction
Intervention: Behavioral: questionnaires
26 Recruiting C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
Condition: Ovarian Cancer, Hereditary Ovarian Cancer Syndrome
Intervention:
27 Recruiting Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
Condition: Malignant Neoplasm of Fallopian Tube
Intervention: Other: PCR for chlamydia DNA in primary tubal cancer
28 Completed Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Healthy Volunteers
Intervention: Drug: Tc 99m EC20
29 Completed Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.
Condition: Ovarian Cancer
Intervention: Behavioral: Individualised follow-up
30 Terminated Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Procedure: Seprafilm™
31 Recruiting Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Condition: Ovarian Cancer
Intervention:
32 Recruiting Streamlining the Delivery of Genetic Testing in the Ovarian Cancer Context: A Pilot Study of Patient Outcomes
Condition: Ovarian Cancer
Intervention: Behavioral: Assessments
33 Active, not recruiting Masitinib in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Masitinib (AB1010);   Drug: Gemcitabine
34 Unknown  Epidemiology of Ovarian Cancer in Taiwan
Condition: Ovarian Cancer
Intervention:
35 Withdrawn Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Azacitidine
36 Completed ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: Sagopilone (ZK 219477) + carboplatin
37 Active, not recruiting Chemotherapy-Related Toxicities In Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Questionnaire
38 Completed A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
Condition: Platinum Sensitive Ovarian Cancer
Interventions: Drug: Active comparator: Niraparib;   Drug: placebo
39 Active, not recruiting M. D. Anderson Symptom Inventory - Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Survey
40 Not yet recruiting Cost Utility of Radical Surgery in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: Collection of additional data with questionnaires

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.